The neurokinin-1 receptor antagonist LY306,740 blocks nociception- induced increases in dorsal horn neurokinin-1 receptor gene expression

Molecular Pharmacology

Volumn 50, Issue 5, 1996, Pages 1189-1199

  McCarson, Kenneth E ^a,b   Krause, James E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LY 306740; LY 307679; MESSENGER RNA; NEUROKININ 1 RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; GENE EXPRESSION REGULATION; INTRON; LONG TERM POTENTIATION; MALE; MOLECULAR STABILITY; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; RAT; RECEPTOR DENSITY; RNA TRANSCRIPTION; SECOND MESSENGER; SEQUENCE ANALYSIS; SPINAL CORD DORSAL HORN; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION;

ACETAMIDES; ANIMALS; DNA, COMPLEMENTARY; FORMALDEHYDE; GENE EXPRESSION REGULATION; INTRONS; MALE; NEURONS; NOCICEPTORS; PLASMIDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROKININ-1; RNA; RNA PROBES; RNA, MESSENGER; SPINAL CORD; SUBCELLULAR FRACTIONS;

EID: 0029844931     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Yokota, Y., Y. Sasai, K. Tanaka, T. Fujiwara, K. Tsuchida, R. Shigemoto, A. Kakizuka, H. Ohkubo, and S. Nakanishi. Molecular characterization of a functional cDNA for rat substance P receptor. J. Biol. Chem. 264:17649-17652 (1989).
2. Hershey, A. D., and J, E. Krause. Molecular characterization of a functional cDNA encoding the rat substance P receptor. Science (Washington D. C.) 247:958-962 (1990).
3. Hanley, M. R., C. M. Lee, L. M. Jones, and R. H. Michell. Similar effects of substance P and related peptides on salivation and on phosphatidylinositol turnover in rat salivary glands. Mol. Pharmacol. 18:78-83 (1980).
4. 2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate, Nature (Land.) 306:67-69 (1983).
5. Kishimoto, A., Y. Takai, T. Mori, U. Kikkawa, and Y. Nishizuka. Activation of calcium and phospholipid-dependent protein kinase by diacylglycerol: its possible relation to phosphatidylinositol turnover. J. Biol. Chem. 255:2273-2276 (1980).
6. Malmberg, A. B., and T. L. Yaksh. Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science (Washington D. C.) 257:1276-1279 (1992).
7. Krause, J. E., P. Blount, and B. S. Sachais. Molecular biology of receptors: structures, expression and regulatory mechanisms, in The Tachykinin Receptors (Buck, S. H., ed.). Humana Press, Totowa, NJ (1994).
8. Otsuka, M., and Yoshioka, K. Neurotransmitter functions of mammalian tachykinins. Physiol. Rev. 73:229-308 (1993).
9. DeKoninck, Y., A. Ribeiro-da-Silva, J. L. Henry, and C. Cuello. Spinal neurons exhibiting a specific nociceptive response receive abundant substance P-containing synaptic contacts. Proc. Natl. Acad. Sci. USA 89: 5073-5077 (1992).
10. Henry, J. L. Effects of substance P on functionally identified units in cat spinal cord. Brain Res. 114:439-451 (1976).
11. Piercey, M. F., P. J. K. Dobry, L. A. Schroeder, and F. J. Einspahr. Behavioral evidence that substance P may be a spinal cord sensory neurotransmitter. Brain Res. 210:407-412 (1981).
12. Tjolsen, A., O.-G. Berge, S. Hunskaar, J. H. Rosland, and K. Hole. The formalin test: an evaluation of the method. Pain 51:5-17 (1992).
13. Noguchi, K., Y. Morita, H. Kiyama, K. Ono, and M. Tohyama. A noxious stimulus induces the preprotachykinin-A gene expression in the rat dorsal root ganglion: a quantitative study using in situ hybridization histochemistry. Mol. Brain. Res. 4:31-35 (1988).
14. McCarson, K. E., and J. E. Krause. NK-1 and NK-3 type tachykinin receptor mRNA expression in the rat spinal cord dorsal horn is increased during adjuvant or formalin-induced nociception. J. Neurosci. 14:712-720 (1994).
15. McCarson, K. E., and J. E. Krause. The formalin-induced expression of tachykinin peptide and neurokinin receptor messenger RNAs in rat sensory ganglia and spinal cord is modulated by opiate preadministration. Neuroscience 64:729-739 (1995).
16. Yamamoto, Y., and T. L. Yaksh. Stereospecific effects of a nonpeptidic NK1 selective antagonist, CP-96,345: antinociception in the absence of motor dysfunction. Life Science 49:1955-1963 (1991).
17. Nagahisa, A., Y. Kanai, O. Suga, K. Taniguchi, M. Tsuchiya, J. A. Lowe, and H. J. Hess. Antiinflammatory and analgesic activity of a non-peptide substance P receptor antagonist. Eur. J. Pharmacol. 217:191-195 (1992).
18. Yashpal, K., V. Radhakrishnan, T. J. Coderre, and J. L. Henry. CP-96,345, but not its stereoisomer, CP-96,344, blocks the nociceptive responses to intrathecally administered substance P and to noxious thermal and chemical stimuli in the rat. Neuroscience 52:1039-1047 (1993).
19. Hershey, A. D., P. E. Dykema, and J. E. Krause. Organization, structure and expression of the gene encoding the rat substance P. J. Biol. Chem. 266:4366-4374 (1991).
20. Mantyh, P. W., E. DeMaster, A. Malhotra, J. R. Ghilardi, S. D. Rogers, C. R. Mantyh, H. Liu, A. I. Basbaum, S. K. Vigna, J. E. Maggio, and D. A. Simone. Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation. Science (Washington D. C.) 268:1629-1631 (1995).
21. Garland, A. M., E. F. Grady, M. Lovett, S. R. Vigna, M. M. Frucht, J. E. Krause, and N. W. Bunnett. Mechanisms of desensitization and resensitization of G protein-coupled neurokinin-1 and neurokinin-2 receptors. Mol. Pharmacol. 49:438-446 (1996).
22. Hipskind, P. A., J. J. Howbert, R. F. Bruns, S. S. Y. Cho, T. A. Crowell, M. M. Foreman, D. R. Gehlert, S. Iyengar, K. W. Johnson, J. H. Krushinski, D. L. Li, K. L. Lobb, N. R. Mason, B. S. Muehl, J. A. Nixon, L. A. Phebus, D. Regoli, R. M. Simmons, P. G. Threlkeld, D. C. Waters, and B. D. Gitter. 3-Aryl-1,2-diacetamidopropane derivatives as novel and potent NK-1 receptor antagonists. J. Med. Chem. 39:736-748 (1996).
23. deSousa, B. N., and L. A. Horrocks. Development of rat spinal cord. I. Weight and length with a method for rapid removal. Dev. Neurosci. 2:115-121 (1979).
24. Krause, J. E., and H. J. Karavolas. Pituitary 5α-dihydroprogesterone 3α-hydroxysteroid oxidoreductases: subcellular location and properties. J. Biol. Chem. 255:11807-11814 (1980).
25. Chomczynski P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159 (1987).
26. Krause, J. E., J. D. Cremins, M. S. Carter, E. R. Brown, and M. R. MacDonald. Solution hybridization-nuclease protection assays for sensitive detection of differentially spliced substance P- and neurokinin A-encoding messenger ribonucleic acids. Methods Enzymol. 168:634-652 (1989).
27. Tsuchida, K., R. Shigemoto, Y. Yokota, and S. Nakanishi. Tissue distribution and quantitation of mRNAs for three rat tachykinin receptors. Eur. J. Biochem. 193:751-757 (1990).
28. Landick, R., J. Carey, and C. Yanofsky. Detection of transcription-pausing in vivo in the trp operon leader region. Proc. Natl. Acad. Sci. USA 84: 1507-1511 (1987).
29. Green, M. R. Biochemical mechanisms of constitutive and regulated pre-mRNA splicing. Annu. Rev. Cell. Biol. 7:559-599 (1991).
30. Padgett, R. A., P. J. Grabowski, M. M. Konarska, S. Seiler, and P. A. Sharp. Splicing of messenger RNA precursors. Annu. Rev. Biochem. 55: 1119-1150 (1986).
31. Qian, L., L. Theodor, M. Carter, M. N. Vu, A. W. Sasaki, and M. F. Wilkinson. T cell receptor-β mRNA splicing: regulation of unusual splicing intermediates. Mol. Cell Biol. 13:1686-1696 (1993).
32. Chandler, L. A., C. P. Ehretsmann, and S. Bourgeois. A novel mechanism of Ha-ras oncogene action: regulation of fibronectin mRNA levels by a nuclear posttranscriptional event. Mol. Cell. Biol. 14:3085-3093 (1994).
33. Jarrous, N., and R. Kaempfer. Induction of human interleukin-1 gene expression by retinoic acid and its regulation at processing of precursor transcripts. J. Biol. Chem. 269:23141-23149 (1994).
34. Ihara, H., and S. Nakanishi. Selective inhibition of expression of the substance P receptor mRNA in pancreatic acinar AR42J cells by glucocorticoids. J. Biol. Chem. 265:22441-22445 (1990).
35. Sachs, A. B. Messenger RNA degradation in eukaryotes. Cell 74:413-421 (1993).
36. Schäfer, M. K. H., D. Nohr, J. E. Krause, and E. Weihe. Inflammation-induced upregulation of NK-1 receptor mRNA in dorsal horn neurones. Neuroreport 4:1007-1010 (1993).
37. 2-adrenergic receptor gene in response to short-term agonist exposure. Proc. Natl. Acad. Sci. USA 86: 4853-4857 (1989).
38. 3 cells. Endocrinology 129:3430-3432 (1991).
39. Habecker, B. A., H. Wang, and N. M. Nathanson. Multiple second-messenger pathways mediate agonist regulation of muscarinic receptor mRNA expression. Biochemistry 32:4986-4990 (1993).
40. Wang, H., D. L. Segaloff, and M. Ascoli. Epidermal growth factor and phorbol esters reduce the levels of the cognate mRNA for the LH/CG receptor. Endocrinology 128:2651-2653 (1991).